{"id":"https://openalex.org/W7225569734","doi":"https://doi.org/10.1161/circ.154.suppl_1.9092","title":"Abstract 9092: Long-Term Efficacy and Safety of Enlicitide in an Open-Label Extension Study","display_name":"Abstract 9092: Long-Term Efficacy and Safety of Enlicitide in an Open-Label Extension Study","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225569734","doi":"https://doi.org/10.1161/circ.154.suppl_1.9092"},"language":"en","primary_location":{"id":"doi:10.1161/circ.154.suppl_1.9092","doi":"https://doi.org/10.1161/circ.154.suppl_1.9092","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.9092","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052604218","display_name":"Christie Mitchell Ballantyne","orcid":"https://orcid.org/0000-0002-6432-1730","observed_orcids":["https://orcid.org/0000-0002-6432-1730"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christie Ballantyne","raw_affiliation_strings":["Baylor College Medicine, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College Medicine, Houston, TX","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161263518","display_name":"Johnathan Parham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Johnathan Parham","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161269860","display_name":"Jodi Carrillo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jodi Carrillo","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072623076","display_name":"Puja Banka","orcid":"https://orcid.org/0000-0002-1407-2705","observed_orcids":["https://orcid.org/0000-0002-1407-2705"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Puja Banka","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091523473","display_name":"Alberico Luigi Catapano","orcid":"https://orcid.org/0000-0002-7593-2094","observed_orcids":["https://orcid.org/0000-0002-7593-2094"]},"institutions":[{"id":"https://openalex.org/I4210094922","display_name":"MultiMedica","ror":"https://ror.org/01h8ey223","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094922","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alberico L Catapano","raw_affiliation_strings":["Univ of Milan; IRCCS Multimedica, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Milan; IRCCS Multimedica, Milano, Italy","institution_ids":["https://openalex.org/I4210094922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078515650","display_name":"Dirk Jacobus Blom","orcid":"https://orcid.org/0000-0003-3965-5912","observed_orcids":["https://orcid.org/0000-0003-3965-5912"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Dirk J Blom","raw_affiliation_strings":["Univ of Cape Town, Cape Town, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Cape Town, Cape Town, South Africa","institution_ids":["https://openalex.org/I157614274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103086675","display_name":"Alberto Cadena","orcid":"https://orcid.org/0000-0001-8913-0319","observed_orcids":["https://orcid.org/0000-0001-8913-0319"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alberto Cadena","raw_affiliation_strings":["Cl\u00ednica de la Costa, Barranquilla, Colombia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cl\u00ednica de la Costa, Barranquilla, Colombia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043161884","display_name":"Norman E. Lepor","orcid":"https://orcid.org/0000-0002-4777-5714","observed_orcids":["https://orcid.org/0000-0002-4777-5714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Norman E Lepor","raw_affiliation_strings":["National Heart Institute, Beverly Hills, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Heart Institute, Beverly Hills, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089204761","display_name":"Kazuhisa Tsukamoto","orcid":"https://orcid.org/0000-0002-4166-6664","observed_orcids":["https://orcid.org/0000-0002-4166-6664"]},"institutions":[{"id":"https://openalex.org/I87531838","display_name":"Teikyo University","ror":"https://ror.org/01gaw2478","country_code":"JP","type":"education","lineage":["https://openalex.org/I87531838"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhisa Tsukamoto","raw_affiliation_strings":["Teikyo Univ Sch of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teikyo Univ Sch of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I87531838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092178112","display_name":"Julio E Nuez Llota","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julio E Nuez Llota","raw_affiliation_strings":["Univ Hosp of Valencia, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ Hosp of Valencia, Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107930477","display_name":"Jean\u2010Claude Tardif","orcid":"https://orcid.org/0000-0002-8200-8983","observed_orcids":["https://orcid.org/0000-0002-8200-8983"]},"institutions":[{"id":"https://openalex.org/I2800290161","display_name":"Montreal Heart Institute","ror":"https://ror.org/03vs03g62","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800290161","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jean-Claude Tardif","raw_affiliation_strings":["Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Montreal Heart Institute, Universit\u00e9 de Montr\u00e9al, Montreal, Canada","institution_ids":["https://openalex.org/I2800290161","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001525341","display_name":"Emil Andreas Asprusten","orcid":"https://orcid.org/0009-0005-9075-3296","observed_orcids":["https://orcid.org/0009-0005-9075-3296"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Emil A Asprusten","raw_affiliation_strings":["Lipid Clinic, Oslo Univ Hosp, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lipid Clinic, Oslo Univ Hosp, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161265710","display_name":"Russell SCOTT","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Russell SCOTT","raw_affiliation_strings":["NZ Clinical Rsch, Christchurch, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NZ Clinical Rsch, Christchurch, New Zealand","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161290737","display_name":"Weiwei He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weiwei He","raw_affiliation_strings":["Merck & Co., Inc., Rahway, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, PA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161283552","display_name":"Przem Gorski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Przem Gorski","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065153173","display_name":"Laura A. Gellis","orcid":"https://orcid.org/0000-0003-4070-4478","observed_orcids":["https://orcid.org/0000-0003-4070-4478"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Gellis","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055745255","display_name":"Erik S. G. Stroes","orcid":"https://orcid.org/0000-0001-9555-6260","observed_orcids":["https://orcid.org/0000-0001-9555-6260"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4405257531","display_name":"Amsterdam Cardiovascular Sciences","ror":"https://ror.org/05c9qnd49","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4405257531"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Erik S Stroes","raw_affiliation_strings":["Dept of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Univ of Amsterdam, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Univ of Amsterdam, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I4405257531","https://openalex.org/I887064364"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048673551","display_name":"Ann Marie N\u00e1var","orcid":"https://orcid.org/0000-0002-6197-9860","observed_orcids":["https://orcid.org/0000-0002-6197-9860"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Marie Navar","raw_affiliation_strings":["Dept of Medicine, Div of Cardiology, Univ of Texas Southwestern Med Cntr, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept of Medicine, Div of Cardiology, Univ of Texas Southwestern Med Cntr, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":12,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"154","issue":"Suppl_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.9639999866485596},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.7020000219345093},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7419999837875366},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7789999842643738},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.5659999847412109},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.7990000247955322},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9240000247955322},{"id":"https://openalex.org/keywords/atherosclerotic-cardiovascular-disease-prevention","display_name":"atherosclerotic cardiovascular disease prevention","score":0.8259999752044678},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ldl-c-target-attainment","display_name":"LDL-C goal attainment","score":0.5170000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9369999766349792},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8847000002861023},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.7232999801635742},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5562000274658203},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41029998660087585},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4072999954223633},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.39719998836517334},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3723999857902527},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.33149999380111694},{"id":"https://openalex.org/C2909478654","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Atherosclerotic cardiovascular disease","level":3,"score":0.3100000023841858},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.28769999742507935},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2872999906539917},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.27970001101493835},{"id":"https://openalex.org/C2779318504","wikidata":"https://www.wikidata.org/wiki/Q1438035","display_name":"Research design","level":2,"score":0.27869999408721924},{"id":"https://openalex.org/C3018127138","wikidata":"https://www.wikidata.org/wiki/Q389735","display_name":"Cardiovascular event","level":3,"score":0.2734000086784363},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2522999942302704}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.154.suppl_1.9092","doi":"https://doi.org/10.1161/circ.154.suppl_1.9092","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.154.suppl_1.9092","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7164171533","https://openalex.org/W7153230817","https://openalex.org/W7127574708","https://openalex.org/W7222136644","https://openalex.org/W7208479309","https://openalex.org/W7202364088","https://openalex.org/W7163805203","https://openalex.org/W7203830056","https://openalex.org/W7160444178","https://openalex.org/W7225399362"],"abstract_inverted_index":{"Background:":[0],"Although":[1],"LDL":[2],"cholesterol":[3],"(LDL-C)":[4],"lowering":[5,34,349],"is":[6,22,94],"foundational":[7],"to":[8,17,121,161,193,244,304,333,352],"atherosclerotic":[9],"cardiovascular":[10],"disease":[11],"(ASCVD)":[12],"prevention,":[13],"many":[14],"patients":[15],"fail":[16],"reach":[18],"LDL-C":[19,33,288,348],"goals.":[20],"Enlicitide":[21],"an":[23,77],"oral,":[24],"once-daily":[25],"PCSK9":[26],"inhibitor":[27],"(PCSK9i)":[28],"that":[29,99],"demonstrated":[30],"robust,":[31],"placebo-corrected":[32],"of":[35,56,69,81,107,229,235,257,326,336,355,360],"~60%":[36],"through":[37,176,292],"52":[38],"weeks":[39],"in":[40,74,76,141,157,164,195,214,282,323],"Phase":[41],"3":[42],"studies":[43,371],"and":[44,54,66,203,271,312],"was":[45,153,169,200,217,260,284,362],"well":[46],"tolerated;":[47],"however,":[48],"longer-term":[49,334],"data":[50,79,175],"on":[51,126],"efficacy,":[52],"safety,":[53],"tolerability":[55,65,377],"enlicitide":[57,70,147,345],"remain":[58],"limited.":[59],"Research":[60],"Questions:":[61],"We":[62],"evaluated":[63],"the":[64,82,137,142,158,165,177,196,215,226,233,258,307,365,368],"sustained":[67,291],"efficacy":[68],"20":[71,148],"mg":[72,149],"daily":[73],"participants":[75,140,239],"interim":[78,236,343],"review":[80],"ongoing":[83],"open-label":[84,97,341],"extension":[85,143,166,259,342],"(OLE)":[86],"study,":[87],"CORALreef":[88,91,111,113,116],"Extension.":[89],"Methods:":[90],"Extension":[92],"(NCT06492291)":[93],"a":[95,221],"single-arm,":[96],"study":[98,127,130,160],"enrolled":[100],"adults":[101],"with":[102,132,146,220,364,372],"hypercholesterolemia":[103],"who":[104],"completed":[105],"one":[106],"three":[108],"parent":[109,159,227,370],"studies:":[110],"Lipids,":[112],"HeFH,":[114],"or":[115,376],"AddOn.":[117],"Participants":[118],"were":[119,144,205,290,309,317],"eligible":[120,188],"enroll":[122,194],"if":[123],"they":[124],"remained":[125],"intervention":[128],"at":[129],"end":[131],"compliance":[133],"\u2265":[134,324],"80%":[135],"during":[136,306],"trial.":[138],"All":[139],"treated":[145],"once":[150],"daily.":[151],"Efficacy":[152],"assessed":[154],"from":[155,251,295,367],"baseline":[156,253,297],"Week":[162,255,293],"8":[163,256],"period.":[167],"Safety":[168],"summarized":[170],"using":[171],"adverse":[172],"event":[173],"(AE)":[174],"cutoff":[178],"date":[179],"for":[180,264,269,275],"this":[181,340],"analysis":[182,359],"(19":[183],"January":[184],"2026).":[185],"Results:":[186],"Among":[187],"participants,":[189],"2,774":[190],"(>87%)":[191],"opted":[192],"extension.":[197],"Mean":[198,212,246],"age":[199],"62.4":[201],"years":[202,242,354],"61.4%":[204],"male;":[206],"54.9%":[207],"had":[208,240],"prior":[209],"major":[210],"ASCVD.":[211],"exposure":[213,224,243],"OLE":[216,308],"293.9":[218],"days":[219],"total":[222,356],"mean":[223],"(including":[225],"studies)":[228],"476.8":[230],"days.":[231],"At":[232],"time":[234],"analysis,":[237,344],"1014":[238],"\u22651.74":[241],"enlicitide.":[245,337],"(95%":[247,278],"CI)":[248,279],"percent":[249,280],"change":[250,281],"parent-study":[252,296],"until":[254],"-57.5%":[261],"(-58.9,":[262],"-56.2)":[263],"LDL-C,":[265],"-51.5%":[266],"(-52.6,":[267],"-50.4)":[268],"non-HDL-C,":[270],"-49.8%":[272],"(-50.7,":[273],"-48.8)":[274],"apoB;":[276],"median":[277],"Lp(a)":[283],"-27.5%":[285],"(-28.1,":[286],"-25.8).":[287],"reductions":[289],"104":[294],"(Figure).":[298],"In":[299,339],"safety":[300,329,361,375],"analyses,":[301],"discontinuations":[302],"due":[303],"AEs":[305,316],"low":[310],"(1.6%)":[311],"no":[313,373],"drug-related":[314],"serious":[315],"reported.":[318],"No":[319,328],"individual":[320],"AE":[321],"occurred":[322],"5%":[325],"participants.":[327],"concerns":[330],"emerged":[331],"related":[332],"use":[335],"Conclusions:":[338],"provided":[346],"durable":[347],"over":[350],"up":[351],"two":[353],"exposure.":[357],"The":[358],"consistent":[363],"conclusions":[366],"placebo-controlled":[369],"new":[374],"concerns.":[378]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-09T00:00:00"}